Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support

Zhongjun J. Wu, Tao Zhang, Giacomo Bianchi, Xufeng Wei, Ho Sung Son, Kang Zhou, Pablo G. Sanchez, Jose Garcia, Bartley P. Griffith

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The purpose of this study was to evaluate the long-term in-vivo hemodynamics, gas transfer, and biocompatibility of an integrated artificial pump-lung (APL) developed for ambulatory respiratory support. The study was conducted in an ovine model by surgically placing the APL between the right atrium and pulmonary artery. Nine sheep were implanted. Heparin was infused as an anticoagulant. The device flow, gas transfer, and plasma free hemoglobin were measured daily. Hematologic data, platelet activation, and blood biochemistry were assessed twice a week. After 30 days, the sheep were euthanized for postmortem examination. The explanted devices were examined for gross thrombosis. Five sheep survived for 29 to 31 days and were electively terminated. Four sheep died or were terminated early owing to mechanical failure of intravenous lines or device. The APL devices in the 5 long-term animals were capable of delivering an oxygen transfer rate of 148 ± 18 mL/min at a flow rate of 2.99 ± 0.46 L/min with blood oxygen saturation of 96.7% ± 1.3%. The device flow and oxygen transfer were stable over 30 days. The animals had normal end-organ functions except for surgery-related transient alteration in kidney function, liver function, and cell and tissue injury. There was no hemolysis. The device flow path and membrane surface were free of gross thrombus. The APL exhibited the capability of providing respiratory support with excellent biocompatibility, long-term reliability, and the potential for bridging to lung transplant.

Original languageEnglish
Pages (from-to)274-281
Number of pages8
JournalAnnals of Thoracic Surgery
Volume93
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Sheep
Equipment and Supplies
Lung
Oxygen
Thrombosis
Plasma Gases
Platelet Activation
Hemolysis
Heart Atria
Biochemistry
Anticoagulants
Pulmonary Artery
Heparin
Autopsy
Hemoglobins
Gases
Hemodynamics
Transplants
Kidney
Membranes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. / Wu, Zhongjun J.; Zhang, Tao; Bianchi, Giacomo; Wei, Xufeng; Son, Ho Sung; Zhou, Kang; Sanchez, Pablo G.; Garcia, Jose; Griffith, Bartley P.

In: Annals of Thoracic Surgery, Vol. 93, No. 1, 01.01.2012, p. 274-281.

Research output: Contribution to journalArticle

Wu, ZJ, Zhang, T, Bianchi, G, Wei, X, Son, HS, Zhou, K, Sanchez, PG, Garcia, J & Griffith, BP 2012, 'Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support', Annals of Thoracic Surgery, vol. 93, no. 1, pp. 274-281. https://doi.org/10.1016/j.athoracsur.2011.08.076
Wu, Zhongjun J. ; Zhang, Tao ; Bianchi, Giacomo ; Wei, Xufeng ; Son, Ho Sung ; Zhou, Kang ; Sanchez, Pablo G. ; Garcia, Jose ; Griffith, Bartley P. / Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. In: Annals of Thoracic Surgery. 2012 ; Vol. 93, No. 1. pp. 274-281.
@article{21022bd4198c4e5e908d8976bc1e4645,
title = "Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support",
abstract = "The purpose of this study was to evaluate the long-term in-vivo hemodynamics, gas transfer, and biocompatibility of an integrated artificial pump-lung (APL) developed for ambulatory respiratory support. The study was conducted in an ovine model by surgically placing the APL between the right atrium and pulmonary artery. Nine sheep were implanted. Heparin was infused as an anticoagulant. The device flow, gas transfer, and plasma free hemoglobin were measured daily. Hematologic data, platelet activation, and blood biochemistry were assessed twice a week. After 30 days, the sheep were euthanized for postmortem examination. The explanted devices were examined for gross thrombosis. Five sheep survived for 29 to 31 days and were electively terminated. Four sheep died or were terminated early owing to mechanical failure of intravenous lines or device. The APL devices in the 5 long-term animals were capable of delivering an oxygen transfer rate of 148 ± 18 mL/min at a flow rate of 2.99 ± 0.46 L/min with blood oxygen saturation of 96.7{\%} ± 1.3{\%}. The device flow and oxygen transfer were stable over 30 days. The animals had normal end-organ functions except for surgery-related transient alteration in kidney function, liver function, and cell and tissue injury. There was no hemolysis. The device flow path and membrane surface were free of gross thrombus. The APL exhibited the capability of providing respiratory support with excellent biocompatibility, long-term reliability, and the potential for bridging to lung transplant.",
author = "Wu, {Zhongjun J.} and Tao Zhang and Giacomo Bianchi and Xufeng Wei and Son, {Ho Sung} and Kang Zhou and Sanchez, {Pablo G.} and Jose Garcia and Griffith, {Bartley P.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.athoracsur.2011.08.076",
language = "English",
volume = "93",
pages = "274--281",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support

AU - Wu, Zhongjun J.

AU - Zhang, Tao

AU - Bianchi, Giacomo

AU - Wei, Xufeng

AU - Son, Ho Sung

AU - Zhou, Kang

AU - Sanchez, Pablo G.

AU - Garcia, Jose

AU - Griffith, Bartley P.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The purpose of this study was to evaluate the long-term in-vivo hemodynamics, gas transfer, and biocompatibility of an integrated artificial pump-lung (APL) developed for ambulatory respiratory support. The study was conducted in an ovine model by surgically placing the APL between the right atrium and pulmonary artery. Nine sheep were implanted. Heparin was infused as an anticoagulant. The device flow, gas transfer, and plasma free hemoglobin were measured daily. Hematologic data, platelet activation, and blood biochemistry were assessed twice a week. After 30 days, the sheep were euthanized for postmortem examination. The explanted devices were examined for gross thrombosis. Five sheep survived for 29 to 31 days and were electively terminated. Four sheep died or were terminated early owing to mechanical failure of intravenous lines or device. The APL devices in the 5 long-term animals were capable of delivering an oxygen transfer rate of 148 ± 18 mL/min at a flow rate of 2.99 ± 0.46 L/min with blood oxygen saturation of 96.7% ± 1.3%. The device flow and oxygen transfer were stable over 30 days. The animals had normal end-organ functions except for surgery-related transient alteration in kidney function, liver function, and cell and tissue injury. There was no hemolysis. The device flow path and membrane surface were free of gross thrombus. The APL exhibited the capability of providing respiratory support with excellent biocompatibility, long-term reliability, and the potential for bridging to lung transplant.

AB - The purpose of this study was to evaluate the long-term in-vivo hemodynamics, gas transfer, and biocompatibility of an integrated artificial pump-lung (APL) developed for ambulatory respiratory support. The study was conducted in an ovine model by surgically placing the APL between the right atrium and pulmonary artery. Nine sheep were implanted. Heparin was infused as an anticoagulant. The device flow, gas transfer, and plasma free hemoglobin were measured daily. Hematologic data, platelet activation, and blood biochemistry were assessed twice a week. After 30 days, the sheep were euthanized for postmortem examination. The explanted devices were examined for gross thrombosis. Five sheep survived for 29 to 31 days and were electively terminated. Four sheep died or were terminated early owing to mechanical failure of intravenous lines or device. The APL devices in the 5 long-term animals were capable of delivering an oxygen transfer rate of 148 ± 18 mL/min at a flow rate of 2.99 ± 0.46 L/min with blood oxygen saturation of 96.7% ± 1.3%. The device flow and oxygen transfer were stable over 30 days. The animals had normal end-organ functions except for surgery-related transient alteration in kidney function, liver function, and cell and tissue injury. There was no hemolysis. The device flow path and membrane surface were free of gross thrombus. The APL exhibited the capability of providing respiratory support with excellent biocompatibility, long-term reliability, and the potential for bridging to lung transplant.

UR - http://www.scopus.com/inward/record.url?scp=84055222760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055222760&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2011.08.076

DO - 10.1016/j.athoracsur.2011.08.076

M3 - Article

C2 - 22115337

AN - SCOPUS:84055222760

VL - 93

SP - 274

EP - 281

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -